The 22 references in paper S. Oranskiy P., L. Yeliseyeva N., V. Kurinnaya P., A. Davydova F., С. Оранский П., Л. Елисеева Н., В. Куринная П., А. Давыдова Ф. (2014) “Нефринурия при нефротическом синдроме у пациентов с ревматоидным артритом // Nephrinuria in patients with nephrotic syndrome secondary to rheumatoid arthritis” / spz:neicon:nefr:y:2014:i:5:p:23-27

1
Ronconi E, Mazzinghi B, Sagrinati C et al. The role of podocyte damage in thepathogenesis of glomerulosclerosis and possible repair mechanisms. G Ital Nefrol 2009; 26 (6): 660-669
(check this in PDF content)
2
Mundel P, Shankland J. Podocyte Biology and Response to Injury. J Am Soc Nephrol 2002; 13: 3005–3015
(check this in PDF content)
3
Kerjaschki D. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001; 108: 1583-1587
(check this in PDF content)
4
Nakamura T, Ushiyama C, Suzuki S et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000; 15: 1379–1383
(check this in PDF content)
5
Nakamura T, Ushiyama C, Suzuki S et al. Urinary podocytes for the assessment of disease activity in lupus nephritis. Am J Med Sci 2000; 320: 112–116
(check this in PDF content)
6
Pagtalunan ME, Miller PL, Jumping-Eagle S et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342–348
(check this in PDF content)
7
Son GH, Kwon JY, Lee S et al. Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2013; 166(2): 139-144
(check this in PDF content)
8
Чеботарева НВ, Бобкова ИН, Козловская ЛВ. Нефринурия как показатель структурно-функциональных нарушений гломерулярного фильтра у больных протеинурическими формами нефрита. Клиническая нефрология 2010; 4: 45-51
(check this in PDF content)
9
Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229-233
(check this in PDF content)
10
Dougados M, Soubrier M, Antunez A.Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014; 73: 62-68
(check this in PDF content)
11
Koseki Y, Terai C, Moriguchi M et al. A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 2001; 60: 327-331
(check this in PDF content)
12
Hickson LJ, Crowson CS, Gabriel SE et al. Development of Reduced Kidney Function in Rheumatoid Arthritis. Am J Kidney Dis 2014; 63(2): 206-213
(check this in PDF content)
13
Boers M, Dijkmans BAC, Breedenveld FC et al. Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum 1990; 33: 95-101
(check this in PDF content)
14
Pathan E, Joshi VR. Rheumatoid arthritis and the kidney. J Assoc Physicians India 2004; 52: 488-494
(check this in PDF content)
15
Karstila K, Korpela M, Sihvonen S, Mustonen J. Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol 2007; 26 (12): 2089-2095
(check this in PDF content)
16
Koop K, Eikmans M, Baelde HJ et al. Expression of podocyte associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071
(check this in PDF content)
17
Aaltonen P, Holth H. The nephrin-based slit diaphragm: new insight into the signalling platform identifies targets for therapy. Nephrol Dial Transplant 2007; 22 (12): 3408-3410
(check this in PDF content)
18
Miner J.H. Focusing on the glomerular slit diaphragm: podocin enters the picture. Am J Pathol 2002; 160(1): 3-5
(check this in PDF content)
19
Hara M, Yanagihara T, Kihara I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis. Clin J Am Soc Nephrol
(check this in PDF content)
20
7; 2 (2): 231-238 20. Lemley KV, Lafayette A, Safai G et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61: 1475-1485
(check this in PDF content)
21
Huh W, Kim DJ, Kim MK, Kim YG, Oh HY, Ruotsalainen V, Tryggvason K. Expression of nephrin in acquired human glomerular disease. Nephrol Dial Transplant 2002;17(3): 478-484
(check this in PDF content)
22
Petrakis I, Mavroeidi V, Stylianou K et al. Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis. Amyloid 2013; 20 (3):164-172 Авторы заявляют об отсутствии конфликта
(check this in PDF content)